JP2024506861A5 - - Google Patents
Info
- Publication number
- JP2024506861A5 JP2024506861A5 JP2023546560A JP2023546560A JP2024506861A5 JP 2024506861 A5 JP2024506861 A5 JP 2024506861A5 JP 2023546560 A JP2023546560 A JP 2023546560A JP 2023546560 A JP2023546560 A JP 2023546560A JP 2024506861 A5 JP2024506861 A5 JP 2024506861A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- pharmaceutically acceptable
- cns
- acceptable salt
- sequestering agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163144441P | 2021-02-01 | 2021-02-01 | |
| US63/144,441 | 2021-02-01 | ||
| PCT/US2022/014695 WO2022165407A1 (en) | 2021-02-01 | 2022-02-01 | Sequestration compounds for treatment of substance use disorder and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506861A JP2024506861A (ja) | 2024-02-15 |
| JP2024506861A5 true JP2024506861A5 (https=) | 2025-02-06 |
Family
ID=82654907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546560A Pending JP2024506861A (ja) | 2021-02-01 | 2022-02-01 | 物質使用障害の治療のための隔離化合物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12569478B2 (https=) |
| EP (1) | EP4284506A4 (https=) |
| JP (1) | JP2024506861A (https=) |
| KR (1) | KR20230167020A (https=) |
| CN (1) | CN117858728A (https=) |
| AU (1) | AU2022213437A1 (https=) |
| BR (1) | BR112023015462A2 (https=) |
| CA (1) | CA3207013A1 (https=) |
| IL (1) | IL304837A (https=) |
| MX (1) | MX2023009055A (https=) |
| WO (1) | WO2022165407A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020245535B2 (en) | 2019-03-26 | 2022-06-30 | Pinova Therapeutics Inc. | Devices and methods for delivering pharmaceutical compositions |
| CA3207013A1 (en) | 2021-02-01 | 2022-08-04 | Xinhua Li | Sequestration compounds for treatment of substance use disorder and uses thereof |
| US11278709B1 (en) | 2021-03-12 | 2022-03-22 | Pocket Naloxone Corp. | Drug delivery device and methods for using same |
| AU2024303746A1 (en) * | 2023-06-16 | 2026-01-22 | Clear Scientific, Inc. | Sequestrant compounds for alpha 2 adrenergic agonists |
| WO2025184478A1 (en) * | 2024-03-01 | 2025-09-04 | Temple University-Of The Commonwealth System Of Higher Education | Reversal agents for ultra-potent synthetic opioid-induced overdose and respiratory depression |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE375149T1 (de) * | 2003-07-25 | 2007-10-15 | Euro Celtique Sa | Behandlung von entzug |
| ES2702848T3 (es) * | 2011-02-23 | 2019-03-05 | Coeruleus Ltd | Complejos de flumazenil, composiciones que los comprenden y usos de los mismos |
| CA2875384A1 (en) * | 2013-12-20 | 2015-06-20 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
| US10874358B2 (en) * | 2015-12-22 | 2020-12-29 | Joseph Insler | Method and device for automatic identification of an opioid overdose and injection of an opioid receptor antagonist |
| IL312012A (en) * | 2016-11-18 | 2024-06-01 | Opiant Pharmaceuticals Inc | Compositions and methods for the treatment of opioid overdose |
| EP3833346A4 (en) * | 2018-08-08 | 2022-08-03 | Torralva Medical Therapeutics LLC | Compositions for opiate and opioid prevention and reversal, and methods of their use |
| CA3134674A1 (en) * | 2019-04-04 | 2020-10-08 | Intra-Cellular Therapies, Inc. | Methods of treating neuropathic pain |
| US10653690B1 (en) * | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| CA3207013A1 (en) | 2021-02-01 | 2022-08-04 | Xinhua Li | Sequestration compounds for treatment of substance use disorder and uses thereof |
-
2022
- 2022-02-01 CA CA3207013A patent/CA3207013A1/en active Pending
- 2022-02-01 AU AU2022213437A patent/AU2022213437A1/en active Pending
- 2022-02-01 CN CN202280024616.5A patent/CN117858728A/zh active Pending
- 2022-02-01 JP JP2023546560A patent/JP2024506861A/ja active Pending
- 2022-02-01 WO PCT/US2022/014695 patent/WO2022165407A1/en not_active Ceased
- 2022-02-01 BR BR112023015462A patent/BR112023015462A2/pt unknown
- 2022-02-01 MX MX2023009055A patent/MX2023009055A/es unknown
- 2022-02-01 EP EP22746860.0A patent/EP4284506A4/en active Pending
- 2022-02-01 KR KR1020237029974A patent/KR20230167020A/ko active Pending
- 2022-02-10 US US17/669,122 patent/US12569478B2/en active Active
-
2023
- 2023-07-30 IL IL304837A patent/IL304837A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024506861A5 (https=) | ||
| EP1244447B1 (en) | Novel methods and compositions involving opioids and antagonists thereof | |
| US9649282B2 (en) | Diversion- and/or abuse-resistant compositions and methods for making the same | |
| Goodman et al. | Mu opioid receptor antagonists: recent developments | |
| Lewis et al. | The orvinols and related opioids-high affinity ligands with diverse efficacy profiles | |
| EP2506712B1 (en) | Morphinan derivatives for the treatment of drug overdose | |
| US20010047005A1 (en) | Novel methods and compositions involving opioids and antagonists thereof | |
| JP2003528819A5 (https=) | ||
| CA2336902C (en) | Topical compositions comprising an opioid analgesic and an nmda antagonist | |
| JP2010511683A5 (https=) | ||
| JP2008534564A5 (https=) | ||
| JP2004515455A (ja) | オピオイドアンタゴニスト組成物および投薬形態 | |
| KR102082529B1 (ko) | 오피오이드-유도 유해 약역학 반응을 치료하기 위한 시스템 및 방법 | |
| WO2008045556A2 (en) | Novel synergistic opioid-cannabinoid codrug for pain management | |
| CN109641849B (zh) | 氘代右美沙芬的合成方法 | |
| JP2007508325A5 (https=) | ||
| Kamerling et al. | Narcotic analgesics, their detection and pain measurement in the horse: a review | |
| JP2003520234A (ja) | 薬物中毒の治療方法 | |
| WO2009070733A1 (en) | Peripheral phenolic opioid antagonist | |
| JP5089687B2 (ja) | アルコール依存症または薬物依存症の予防または治療剤 | |
| Casy | The structure of narcotic analgesic drugs | |
| JP2020536892A5 (https=) | ||
| US20050113401A1 (en) | Treatment of chemical dependency with substantially nonaddicting normorphine and norcodeine derivatives | |
| JP2007503473A5 (https=) | ||
| IL273904B2 (en) | Medicinal resin components and methods for their production and use |